Correlation Between GlaxoSmithKline PLC and Norsk Hydro

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Norsk Hydro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Norsk Hydro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Norsk Hydro ASA, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Norsk Hydro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Norsk Hydro. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Norsk Hydro.

Diversification Opportunities for GlaxoSmithKline PLC and Norsk Hydro

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between GlaxoSmithKline and Norsk is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Norsk Hydro ASA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Norsk Hydro ASA and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Norsk Hydro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Norsk Hydro ASA has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Norsk Hydro go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Norsk Hydro

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 40.3 times less return on investment than Norsk Hydro. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 2.43 times less risky than Norsk Hydro. It trades about 0.0 of its potential returns per unit of risk. Norsk Hydro ASA is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  605.00  in Norsk Hydro ASA on August 24, 2024 and sell it today you would earn a total of  62.00  from holding Norsk Hydro ASA or generate 10.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.6%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Norsk Hydro ASA

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Norsk Hydro ASA 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Norsk Hydro ASA are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain forward-looking signals, Norsk Hydro reported solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and Norsk Hydro Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Norsk Hydro

The main advantage of trading using opposite GlaxoSmithKline PLC and Norsk Hydro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Norsk Hydro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Norsk Hydro will offset losses from the drop in Norsk Hydro's long position.
The idea behind GlaxoSmithKline PLC ADR and Norsk Hydro ASA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital